课题基金 / 基金详情

Establishment of antigen-specific regulatory T cell lines induced by oral tolerance and the application to immunotherapy

Establishment of antigen-specific regulatory T cell lines induced by oral tolerance and the application to immunotherapy
口服耐受诱导抗原特异性调节性T细胞系的建立及其在免疫治疗中的应用
批准号:
12470113
负责人:
YAMAMOTO Kazuhiko
金额:
$9.92万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2000
资助国家:
日本
项目状态:
已结题
起止时间:
2000 至 2001

项目摘要

项目成果

YAMAMOTO Kazuhiko的其他基金

相似基金

相关文献

中文摘要
翻译
口服耐受是一种很有前途的免疫治疗方法。由口服抗原产生的调节性T细胞将是最负责抑制作用的细胞群。为了建立调节性T细胞系,了解调节性T细胞的机制以及产生这些T细胞的条件是很重要的。因此,我们建立了一种检测系统,通过将候选调节细胞与抗原特异性脾细胞混合来监测对正在进行的免疫反应的抑制活性。我们接下来关注的是分泌tgf -的Th3/Tr1细胞,因为这种细胞是最具特征的调节细胞之一。因此,我们描述了几种产生Th3/Tr1细胞的培养条件。在不同条件下培养OVA特异性TCR转基因小鼠的脾脏细胞,并检测由此产生的OVA特异性细胞的tgf - β分泌或上述建立的评价体系。我们现在正在缩小产生调节细胞的合适条件。
英文摘要
Oral tolerance is one of the promising methods for immunotherapy. Regulatory T cells generated by the orally administered antigens would be the most responsible cell population for the suppressive action. In order to establish regulatory T cell lines, it is important to know the mechanisms of the regulation as well as the conditions to generate these T cells. We thus establish an assay system to monitor the suppressive activity to the ongoing immune-response by mixing the candidate regulatory cells with antigen-specific splenocytes. We next focused on the Th3/Tr1 cells which secrete TGF-beta because this cells is one of the most well characterized regulatory cells. We have thus characterize the several culture conditions to generate Th3/Tr1 cells. Spleen cells from OVA specific TCR transgenic mice were cultured in different conditions and resultant OVA specific cells were assayed for the secretion of TGF-beta or the above established evaluation system. We are now narrowing down suitable conditions for the generation of regulatory cells.
期刊论文(56)
专著(0)
科研奖励(0)
会议论文
Kurokawa M. Tong J. Matsui T. Masuko-Hongo K. Yabe T. Nishikawa K. Yamamto K. Kato T.: "Paired cloning of the T cell receptor α and β genes from a single T cell without the establishment of a T cell clone"Clin. Exp. Immunol.. 123. 340-345 (2000)
Kurokawa M. Tong J. Matsui T. Masuko-Hongo K. Yabe T. Nishikawa K. Yamamto K. Kato T.:“从单个 T 细胞配对克隆 T 细胞受体 α 和 β 基因,无需建立 T细胞克隆“Clin.Exp.Immunol..123.340-345(2000)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Setoguchi K.: "Peroxisome proliferator-activated receptor-r haploinsufficiency enhances B cell proliferative responses and exacerbates experimentally induced arthritis"J.Clin.Invest.. 108. 1667-1675 (2001)
Setoguchi K.:“过氧化物酶体增殖物激活受体-r 单倍体不足增强 B 细胞增殖反应并加剧实验诱导的关节炎”J.Clin.Invest.. 108. 1667-1675 (2001)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Yamamoto K.: "T cell and autoimmune diseases"Allergy International. 50. 1-4 (2001)
Yamamoto K.:“T 细胞和自身免疫性疾病”过敏国际。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Sawabe T.: "Accumulation of common clonal T Cells in multiple lesions of sarcoidosis"Mol. Med.. 6. 793-802 (2000)
Sawabe T.:“结节病多处病变中常见克隆 T 细胞的积累”Mol。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 28 条
    Comparative study on the reforms of civil procedural laws in the era of globalization and innovation
    • 批准号:
      18H00806
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $10.73万
    • 财政年份:
      2018
    • 负责人:
      YAMAMOTO Kazuhiko
    • 依托单位:
    Chemoprevention for oral cancer targeting at microRNA
    • 批准号:
      21592561
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.91万
    • 财政年份:
      2009
    • 负责人:
      YAMAMOTO Kazuhiko
    • 依托单位:
    Pathological roles of a citrullinating enzyme PADI4 in rheumatoid arthritis
    • 批准号:
      20390280
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.98万
    • 财政年份:
      2008
    • 负责人:
      YAMAMOTO Kazuhiko
    • 依托单位:
    A study of sensor for human detection with a property of the skin material
    • 批准号:
      19500080
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.91万
    • 财政年份:
      2007
    • 负责人:
      YAMAMOTO Kazuhiko
    • 依托单位:
    海外基金